30-day notice

PATH 30-day Notice.pdf

Generic Clearance for Cognitive Testing of Instrumentation and Materials for the PATH Study (NIDA)

30-day notice

OMB: 0925-0663

Document [pdf]
Download: pdf | pdf
Federal Register / Vol. 80, No. 198 / Wednesday, October 14, 2015 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

National Institutes of Health

National Institutes of Health

Office of the Director, National
Institutes of Health; Notice of Closed
Meeting

National Institute on Minority Health
and Health Disparities; Notice of
Closed Meeting

Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Scientific and
Technical Review Board on Biomedical and
Behavioral Research Facilities.
Date: October 28, 2015.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Capital View, 2850
South Potomac Avenue, Arlington, VA
22202.
Contact Person: Ross D Shonat, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6196,
MSC 7804, Bethesda, MD 20892, 301–435–
2786, [email protected].
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.

tkelley on DSK3SPTVN1PROD with NOTICES

(Catalogue of Federal Domestic Assistance
Program Nos. 93.14, Intramural Research
Training Award; 93.22, Clinical Research
Loan Repayment Program for Individuals
from Disadvantaged Backgrounds; 93.232,
Loan Repayment Program for Research
Generally; 93.39, Academic Research
Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan
Repayment Program; 93.187, Undergraduate
Scholarship Program for Individuals from
Disadvantaged Backgrounds, National
Institutes of Health, HHS)
Dated: October 7, 2015.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–25995 Filed 10–13–15; 8:45 am]
BILLING CODE 4140–01–P

VerDate Sep<11>2014

16:39 Oct 13, 2015

Jkt 238001

Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable materials,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Minority Health and Health Disparities
Special Emphasis Panel; NIMHD Support for
Conference and Scientific Meetings (R13).
Date: October 26, 2015.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Minority
Health and Health Disparities, Internet
Assisted Meeting, 6707 Democracy Blvd.,
Suite 800, Bethesda, MD 20892
Contact Person: Xinli Nan, M.D., Ph.D.,
Scientific Review Officer, National Institute
on Minority Health and Health Disparities,
National Institutes of Health, 6707
Democracy Blvd., Suite 800, Bethesda, MD
20892, (301) 435–3481, [email protected].
Dated: October 8, 2015.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–26103 Filed 10–13–15; 8:45 am]
BILLING CODE 4140–01–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-Day
Comment Request Population
Assessment of Tobacco and Health
(PATH) Study (NIDA)
Under the provisions of
Section 3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National
Institutes of Health (NIH) has submitted
to the Office of Management and Budget
(OMB) a request for review and
approval of the information collection
listed below. This proposed information
collection was previously published in

SUMMARY:

PO 00000

Frm 00040

Fmt 4703

Sfmt 4703

61829

the Federal Register on June 30, 2015,
pages 37276–37277 and allowed 60 days
for public comment. No public
comments were received. The purpose
of this notice is to allow an additional
30 days for public comment. The
National Institutes of Health may not
conduct or sponsor, and the respondent
is not required to respond to, an
information collection that has been
extended, revised, or implemented on or
after October 1, 1995, unless it displays
a currently valid OMB control number.
Direct Comments to OMB: Written
comments and/or suggestions regarding
the item(s) contained in this notice,
especially regarding the estimated
public burden and associated response
time, should be directed to the: Office
of Management and Budget, Office of
Regulatory Affairs, OIRA_Submission@
omb.eop.gov or by fax to (202) 395–
6974, Attention: NIH Desk Officer.
Comment Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 30 days of the date of
this publication.
FOR FURTHER INFORMATION CONTACT: To
obtain a copy of the data collection
plans and instruments or request more
information on the proposed project,
contact: Dr. Kevin P. Conway, Deputy
Director, Division of Epidemiology,
Services, and Prevention Research,
NIDA, NIH, 6001 Executive Boulevard,
Room 5185, Rockville, MD 20852; or
call non-toll-free number (301) 443–
8755 or Email your request, including
your address to: PATHprojectofficer@
mail.nih.gov. Formal requests for
additional plans and instruments must
be requested in writing.
Proposed Collection: Cognitive
Interviews and Focus Groups for the
Population Assessment of Tobacco and
Health (PATH) Study (NIDA), 0925–
0663, Expiration Date 11/30/2015,
Revision, National Institute on Drug
Abuse, National Institutes of Health
(NIH), in partnership with the Food and
Drug Administration (FDA).
Need and Use of Information
Collection: This is a revision request for
the Population Assessment of Tobacco
and Health (PATH) Study to conduct
cognitive interviews and focus groups,
to support the development of the
Study’s questionnaires and other
materials. The PATH Study is a national
longitudinal cohort study of tobacco use
behavior and health among the U.S.
household population of adults age 18
and older and youth ages 12 to 17; the
Study conducts annual interviews and
collects biospecimens from adults to
inform FDA’s regulatory actions under
the Family Smoking Prevention and

E:\FR\FM\14OCN1.SGM

14OCN1

61830

Federal Register / Vol. 80, No. 198 / Wednesday, October 14, 2015 / Notices

Control Act. Cognitive interviews and
focus groups are qualitative methods to
assess how people interpret, process,
retrieve, and respond to phrases,
questions, response options, and
product images that may be used in the
development of the PATH Study’s

questionnaires and other materials.
These methods have previously been
used to help the PATH Study improve
the comprehensibility of its materials
for Study participants, and to increase
efficiencies in data collection and

reduce duplication and its associated
burden on participants and the public.
OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total
annualized burden hours are 2,617.

ESTIMATED ANNUALIZED BURDEN HOURS
Type of
respondent

Activity name

Completing eligibility screener .............................................
Examining concepts to be measured in PATH Study .........
Examining assent forms for participation in PATH Study ...
Examining consent forms for participation in PATH Study
Examining other forms and materials to support PATH
Study data collection ........................................................
Examining PATH Study questionnaires ...............................

Dated: October 7, 2015.
Genevieve deAlmeida-Morris,
Project Clearance Liaison, NIDA, NIH.
[FR Doc. 2015–26100 Filed 10–13–15; 8:45 am]
BILLING CODE 4140–01–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meetings

tkelley on DSK3SPTVN1PROD with NOTICES

Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel Innovative
Technologies for Cancer Research.
Date: November 5–6, 2015.
Time: 11:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove 9609 Medical Center Drive, Room
7W246 Rockville, MD 20850 (Telephone
Conference Call).
Contact Person: Nicholas J. Kenney, Ph.D.
Scientific Review Officer Research

VerDate Sep<11>2014

18:25 Oct 13, 2015

Jkt 238001

Number of
respondents

Frm 00041

Average
burden per
response
(in hours)

Total annual
burden hours

Youth
Adults
Youth
Adults
Youth
Adults

1,600
2,400
100
200
200
200

1
1
1
1
1
1

10/60
10/60
90/60
90/60
90/60
90/60

267
400
150
300
300
300

Adults
Youth
Adults

200
100
300

1
1
1

90/60
90/60
90/60

300
150
450

Technology and Contract Review Branch
Division of Extramural Activities National
Cancer Institute, NIH 9609 Medical Center
Drive, Room 7W246 Rockville, MD 20850
240–276–6374 [email protected].
Name of Committee: National Cancer
Institute Special Emphasis Panel
Quantitative Imaging for Evaluation of
Responses to Cancer Therapies.
Date: November 12, 2015.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove 9609 Medical Center Drive, Room
7W246 Rockville, MD 20850 (Telephone
Conference Call).
Contact Person: Nicholas J. Kenney, Ph.D.
Scientific Review Officer Research
Technology and Contract Review Branch
Division of Extramural Activities National
Cancer Institute, NIH 9609 Medical Center
Drive, Room 7W246 Rockville, MD 20850
240–276–6374 [email protected].
Name of Committee: National Cancer
Institute Special Emphasis Panel Advanced
Development and Validation of Emerging
Molecular Analysis Technologies for Cancer
Research.
Date: November 18, 2015.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove 9609 Medical Center Drive, Room
2E914 Rockville, MD 20850 (Telephone
Conference Call).
Contact Person: Gerard Lacourciere, Ph.D.
Scientific Review Officer Research
Technology and Contract Review Branch
Division of Extramural Activities National
Cancer Institute, NIH 9609 Medical Center
Drive, Room 7W248 Rockville, MD 20850
240–276–5457 [email protected].
Name of Committee: National Cancer
Institute Special Emphasis Panel NCI Lasker
Clinical Research Scholars Program.
Date: November 19, 2015.

PO 00000

Number of
responses per
respondent

Fmt 4703

Sfmt 4703

Time: 11:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove 9609 Medical Center Drive, Room
7W126 Rockville, MD 20850, (Telephone
Conference Call).
Contact Person: Caron Lyman, Ph.D. Chief,
Scientific Review Officer Research Programs
Review Branch Division of Extramural
Activities National Cancer Institute 9609
Medical Center Drive, Room 7W126
Bethesda, MD 20892–9750 240–276–6348
[email protected].
Name of Committee: National Cancer
Institute Initial Review Group Subcommittee
A—Cancer Centers.
Date: December 4, 2015.
Time: 8:00 a.m. to 10:30 a.m.
Agenda: To review and evaluate grant
applications..
Place: Bethesda North Marriott Hotel &
Conference Center 5701 Marinelli Road
Rockville, MD 20852.
Contact Person: Shamala K. Srinivas, Ph.D.
Associate Director Office of Referral, Review,
and Program Coordination Division Of
Extramural Activities National Cancer
Institute, NIH 9609 Medical Center Drive,
Room 7W530 Bethesda, MD 20892–8328
240–276–6442 [email protected].
Name of Committee: National Cancer
Institute Special Emphasis Panel Cancer
Center Support Grant.
Date: December 4, 2015.
Time: 10:45 a.m. to 12:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel &
Conference Center 5701 Marinelli Road
Bethesda, MD 20852.
Contact Person: David G. Ransom, Ph.D.
Scientific Review Officer Resources and
Training Review Branch Division of
Extramural Activities National Cancer
Institute, NIH 9609 Medical Center Drive,
Room 7W124 Rockville, MD 20850 240–276–
6351 [email protected].

E:\FR\FM\14OCN1.SGM

14OCN1


File Typeapplication/pdf
File Modified2015-10-14
File Created2015-10-14

© 2024 OMB.report | Privacy Policy